University of Bristol continues fight to eradicate deadly disease on World Tuberculosis Day 25 March 2021 Researchers at the University of Bristol are working on a number of different developments to finally end the TB epidemic.
- University of Bristol continues fight to eradicate deadly disease on World Tuberculosis Day 25 March 2021 Researchers at the University of Bristol are working on a number of different developments to finally end the TB epidemic.
- Alumni support Biochemistry students 24 March 2021
- How Bristol’s research has played a key role in the world’s response to COVID-19 23 March 2021 As the COVID-19 pandemic hit the world, academics from across the University of Bristol joined together to understand the virus and the impact of the pandemic. Today [23 March] is a year since the first UK lockdown and their research is continuing to play a key role in global efforts to overcome the disease.
- University commissions sculpture of Henrietta Lacks on International Women’s Day 10 March 2021 The University of Bristol has commissioned local artist Helen Wilson Roe to create a sculpture of Henrietta Lacks, a Black American woman whose human cells were the first ever to survive and multiply outside the body.
- Professor Christiane Berger-Schaffitzel named one of the most influential women in Bristol 8 March 2021 The School of Biochemistry professor is recognised in the BristolLive list.
- The Pride of Bristol: Professor Christiane Berger-Schaffitzel interview with The Bristol Magazine 3 February 2021
- How vitamins, steroids and potential antivirals might affect SARS-CoV-2 28 January 2021 Evidence is emerging that vitamin D – and possibly vitamins K and A – might help combat COVID-19. A new study from the University of Bristol published in the journal of the German Chemical Society Angewandte Chemie has shown how they – and other antiviral drugs – might work. The research indicates that these dietary supplements and compounds could bind to the viral spike protein and so might reduce SARS-CoV-2 infectivity. In contrast, cholesterol may increase infectivity, which could explain why having high cholesterol is considered a risk factor for serious disease.
- Royal Society award enables University researcher to study neurodegenerative disease 15 January 2021 Professor Peter Cullen, a Wellcome Trust Investigator from the School of Biochemistry at the University of Bristol, has been awarded the Royal Society Noreen Murray Professorship to expand his research into neurological sciences.
- World's first research programme to identify scarring gene launched 26 November 2020 A world-leading £1.5 million research programme that aims to achieve scar free healing within a generation has been launched today [26 November] by The Scar Free Foundation, the only medical research charity which focuses solely on scarring. The five-year research study led by the University of Bristol will identify the gene(s) that causes scarring and inform future treatments.
- New type of antivenom to reduce 100,000 fatalities each year from venomous snake bites being developed by Bristol scientists 5 November 2020 A new approach of treating life-threatening snake bites responsible for around 100,000 deaths globally each year is being pioneered by an international research consortium led by University of Bristol scientists. The EU-funded ADDovenom study, involving teams in the UK, France, Belgium and Portugal, set out to create a new type of antivenom treatment to neutralise and eliminate venom toxins from the bloodstream with more efficacy, safety and affordability than what is available today.